BeStock  

Smith & Nephew SNN

US equityMarket cap rank #1255Medical Devices
$29.83 +$0.00 (0.00%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $29.83 0.00%
Open$29.94
Prev close$29.83
Day range$29.81 – $30.25
Volume1.23M
Market cap$12.47B
P/E (TTM)20.3
Dividend yield2.62%

Earnings

Average move on report day±6.1%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+15.2%
Worst reaction-13.0%

Stock move on the day after each report

-6.0%2021/Q2+6.0%2021/Q4-9.8%2022/Q2+5.5%2022/Q4-2.8%2023/Q2-2.0%2023/Q4+6.9%2024/Q2-13.0%2024/Q3+7.0%2024/Q4+15.2%2025/Q2-3.1%2025/Q4-5.3%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q24 Aug 2026None±14.5%-5.32%Within range
2025/Q42 Mar 2026None±14.6%-3.09%Within range
2025/Q25 Aug 2025None–+15.23%–
2024/Q425 Feb 2025None±9.9%+6.96%Within range
2024/Q331 Oct 2024None–-13.03%–
2024/Q21 Aug 2024None±9.0%+6.88%Within range
2023/Q427 Feb 2024None±10.6%-2.00%Within range
2023/Q23 Aug 2023None±7.3%-2.80%Within range
2022/Q421 Feb 2023None±10.4%+5.53%Within range
2022/Q228 Jul 2022None±16.5%-9.85%Within range
2021/Q422 Feb 2022None±11.0%+5.95%Within range
2021/Q229 Jul 2021None±5.5%-6.04%Bigger than priced
2020/Q418 Feb 2021None±6.5%-5.62%Within range
2020/Q229 Jul 2020None±10.4%+0.81%Within range
2019/Q420 Feb 2020None–+7.09%–
2019/Q231 Jul 2019None–+1.23%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2025/FY

By business line

  • Orthopaedics$2.44B 39.5%
  • Sports Medicine & Ear, Nose & Throat (ENT)$1.93B 31.4%
  • Advanced Wound Management$1.79B 29.1%

By region

  • United States of America$3.31B 53.6%
  • Established Markets$1.48B 24.0%
  • Emerging Markets$1.00B 16.3%
  • United Kingdom$246.00M 4.0%
  • China$128.00M 2.1%

Latest reported quarter: Q4, ended Dec 2014

Revenue$1.25B+6.3% YoY
Operating profit$372.00M+21.2% YoY
Net profit$160.00M-1.2% YoY
Diluted EPS$0.36-1.1% YoY
Free cash flow$184.00M-6.1% YoY
Operating cash flow$302.00M

Revenue, last 8 quarters

$1.1BMar '13$1.1BJun '13$1.0BSep '13$1.2BDec '13$1.1BMar '14$1.1BJun '14$1.1BSep '14$1.2BDec '14

Net profit, last 8 quarters

$143.0MMar '13$129.0MJun '13$122.0MSep '13$162.0MDec '13$150.0MMar '14$89.0MJun '14$102.0MSep '14$160.0MDec '14

Profitability & balance sheet

Gross margin68.2%
Operating margin13.9%
Net margin10.1%
Return on equity11.9%
Return on assets5.9%
Return on invested capital8.4%
Current ratio2.14
Liabilities / assets53.0%
Cash & investments$754.00M
Total debt$3.72B
Net cash (debt)-$2.97B
Free cash flow / sales13.6%

Discussion

No comments yet — be the first to weigh in on SNN.

Sign in to join the discussion.

Scroll to Top